PU-H71 With Nab-paclitaxel (Abraxane) in Metastatic Breast Cancer
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Metastatic Breast Cancer
Interventions: DRUG: PU-H71|DRUG: Nab-paclitaxel
Sponsor: Memorial Sloan Kettering Cancer Center
Collaborators: Samus Therapeutics, Inc.